Business Wire

NY-UPFLEX

20.12.2022 15:01:37 CET | Business Wire | Press release

Share
As Enterprises Brace for Economic Turmoil, Upflex Emerges as Flex Category Leader for Office Cost-Cutting Solutions

Upflex, the premier provider of hybrid workspace solutions, is bringing yet another successful year of company growth to a close. This momentum — a testament to flex as a new workplace standard — includes a 400% increase in Upflex’s customer base. Global corporations such as Willis Towers Watson, HH Global, and Schneider Electric, as well as leading tech firms such as Snowflake, Alation and Gympass are among those that have chosen Upflex as their hybrid workspace partner. To serve a fast-growing global demand, Upflex has increased its employee headcount by more than 200% with new hires across 12 countries.

Upflex, which was founded in 2018 by CEO Christophe Garnier and CPO Ginger Dhaliwal, builds technology and solutions to connect companies, space providers, and brokers in one cooperative ecosystem for more manageable, more sustainable flexible work. This year, with flexible workspace options being more important than ever, the company’s platform and flex workspace usage data have been in high demand.

“Since Upflex’s inception, providing a more efficient, flexible, and sustainable way of working has been our core mission,” said Christophe Garnier, CEO and co-founder of Upflex. “In 2022, we have seen that companies across the world are embracing hybrid work, and that they need better solutions for adopting and managing it. We’ve also seen in recent months that enterprise companies are increasingly concerned with cost savings moving toward a potential economic recession, and I’m thrilled that Upflex can be part of the solution for these employers to create new workspace efficiencies that cut real estate costs, so they don’t have to cut their people.”

Earlier this year, Upflex grew its EMEA presence with the acquisition of WorkClub, a UK-based coworking space aggregator, and entered an exclusive, strategic global partnership with WeWork, adding hundreds of WeWork locations to Upflex’s network of thousands of bookable desks, meeting rooms, and private offices around the world. As the sole aggregator of WeWork inventory, Upflex and WeWork clients benefit from enhanced coverage and optionality in workspaces. In May, Upflex announced a $30 million Series A round led by WeWork, with participation from top strategic and venture funds, including Newmark, Cushman & Wakefield, Industry Ventures, Inertia Ventures and GPO Fund.

Other 2022 milestones for Upflex include:

  • Being selected as a finalist in the most prestigious awards in proptech: CRETech’s Real Estate Tech Awards;
  • Expanding from 74 to 120 countries, including China, Japan, Indonesia, and Brazil, and increasing the company’s presence from 875 to 1,250 cities;
  • Expanding Upflex's global workspace network from 4,900 to 10,000 workspace locations and adding 325 operators reaching a total of 1,350 operators;
  • Launching a major partnership with brokerage firm Newmark to power Optality, a white-labeled version of the Upflex app. This partnership expands upon Upflex’s impressive roster of brokerage partners, including Colliers.
  • Expanding its White Label offering to global flex operators including the UK’s largest flex operator Landmark, to make booking and payment instant and seamless for all their users across nearly 50 locations in nine major UK cities;
  • Partnering with Chief Brand Advisory (CBA) in October to launch a reimagined brand strategy, in tandem adding CBA’s Founder, Brad Kay, as an investor and advisor;
  • Continuing its partnership with the non-profit Trees for the Future to plant a tree for every desk booked on its platform. So far, Upflex has planted over 20,000 trees, a significant impact on reducing global carbon emissions and supporting its core mission of sustainability.

“Upflex will continue to invest a tremendous amount of resources to advance the development of our best-in-class hybrid work technology,” said Ginger Dhaliwal, CPO and co-founder of Upflex. “As companies look to make more informed real estate decisions, the future of the evolving workplace lies in utilization data. With Upflex’s real-time employee analytics, companies are able to be proactive in their workplace planning as they work to build sustainable strategies that serve their business, their people, and the planet.”

About Upflex:

Upflex (upflex.com) is a workspace intelligence platform bringing together people, places, and data to deliver the right workplace strategies for forward-thinking companies and their employees, from startups to the Fortune 100. Founded in 2018 as a co-working aggregator and booking platform, the company recently raised $30MM in Series A funding, forged an exclusive partnership with WeWork, and is expanding its operations to strengthen its global network. Today, Upflex has evolved beyond an aggregator, connecting companies, space providers and brokers to create an ecosystem of flexible and sustainable workspace experiences. Upflex leverages technology, services, and insights to make finding and managing global workspaces simple, smarter, and more agile.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221219005473/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

KATE Launches "KABUKE: Break Convention" Kabuki-Inspired International Campaign17.7.2026 09:00:00 CEST | Press release

Where “NO MORE RULES.” intersects with the Kabuku spirit. Inspired by Japanese aesthetics, KATE shares the value of shadow enhancing makeup and self‑expression with the world. Global cosmetics brand KATE launched “KABUKE: Break Convention,” a new international campaign drawing on elements of Kabuki, the traditional Japanese performing art. The campaign debuted on Wednesday, July 8, 2026. In this campaign, KATE’s shadow enhancing makeup—rooted in Japanese aesthetics—was paired with the Kabuki spirit inherited from traditional Kabuki theater to communicate the value of individuality and self‑expression through makeup on a global scale. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708829427/en/ KATE international campaign “KABUKE: Break Convention” key visual. Dedicated website: https://www.kate-global.net/my/special/kate_kabuki/ Since its founding, KATE has championed the slogan “NO MORE RULES.,” offering makeup that defi

Meiji Seika Pharma: Results from the Global Phase III Trial (Integral-2) of Nacubactam, a Novel β-Lactamase Inhibitor, Highlighted in The Lancet Microbe’s Coverage of ESCMID Global Congress 202617.7.2026 03:00:00 CEST | Press release

Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, President and Representative Director: Toshiaki Nagasato) today announced that results from the global Phase III trial (Integral-2) of nacubactam (Development Code: OP0595), a novel β-lactamase inhibitor, were highlighted in The Lancet Microbe’s coverage of ESCMID Global Congress 2026 (held in Munich, Germany). As highlighted in The Lancet Microbe’s coverage, the key findings presented by Meiji Seika Pharma at ESCMID Global Congress 2026 are as follows: The Integral-2 study (jRCT2031230076) is a global Phase III clinical trial that enrolled patients with complicated urinary tract infections, acute uncomplicated pyelonephritis, hospital-acquired bacterial pneumonia, ventilator-associated bacterial pneumonia, or complicated intra-abdominal infections caused by carbapenem-resistant Gram-negative bacteria (excluding Acinetobacter species). The study has achieved the prespecified study objectives. For the primary endpoint of overall treatme

Yoshihiro Shimamura Joins the Marché du Film’s “Investors Circle 2026” as an Invited Investor, Backing a New Feature Film17.7.2026 03:00:00 CEST | Press release

Shimamura Yoshihiro Film Production Co., Ltd. (Head office: Osaka, Japan; Representative Director: Yoshihiro Shimamura), a company active in film production and investment, today announced that Representative Director Yoshihiro Shimamura has decided to invest in an international feature film after being invited to the “Investors Circle 2026” — a distinction that reflects his standing as one of the field’s most highly regarded producers and investors. Hosted by the Marché du Film, the business arm of the Festival de Cannes and one of the world’s largest film markets, the Investors Circle is an invitation-only summit that connects a select group of private investors with high-end feature films during early-stage financing. Held in Cannes, France, May 16-17, 2026, it brings internationally acclaimed directors and producers together with investors around a curated slate of projects in development. During the summit, Shimamura attended private pitching sessions and, after individual meeting

Takeda’s Zasocitinib Demonstrates Consistent, High Rates of Skin Clearance Across the Body, Including Hard-to-Treat and High-Impact Sites, in Phase 3 Psoriasis Studies17.7.2026 00:00:00 CEST | Press release

On average, about 75% of patients with scalp psoriasis treated with zasocitinib achieved clear or almost clear skin at week 16 Approximately 70% of patients with palmoplantar disease treated with zasocitinib achieved clear or almost clear skin at week 16 Zasocitinib demonstrated statistically significant improvements in Nail Psoriasis Severity Index (NAPSI) versus placebo Results reinforce the potential of zasocitinib to deliver rapid and durable skin clearance, including in the hardest-to-treat areas, in a convenient once-daily pill Takeda (TSE:4502/NYSE:TAK) announced new data from the two pivotal Phase 3 studies of zasocitinib (TAK-279), a next-generation, highly selective and potent oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented at the 2026 American Academy of Dermatology (AAD) Innovation Academy, these secondary endpoint data show that zasocitinib demonstrated consistent and high rates of skin clearance across hard-to-

Merz Completes Inaugural €450 Million Schuldschein Loan Issuance16.7.2026 23:36:00 CEST | Press release

Debut transaction more than three times oversubscribed The Merz Group has successfully completed its first-ever Schuldschein loan issuance, placing a total volume of €450 million in the debt capital market – a multiple of three relating to the launch volume. The debut transaction was significantly oversubscribed and attracted strong interest from all investor groups. The proceeds were settled and paid out today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260716926041/en/ Dr. Almuth Steinkühler, Chief Financial Officer Merz Group The transaction comprises both fixed- and floating-rate tranches with maturities of three, five, seven, and ten years. Around 50 German and international investors participated, representing a broad range of institutions, including private banks, German federal state-owned banks, public savings banks, cooperative banks, pension funds and occupational pension institutions. With the successful plac

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye